Automating High-Throughput IgG Quantification
Quantifying IgG samples efficiently is critical for drug development and manufacturing. The Beckman Valita®Titer workflow revolutionizes this process, offering significant advantages over traditional methods like ELISA and HPLC.
Valita Titer Assays for IgG Quantification
Results in minutes not hours.
Valita Titer plate-based, 96- and 384-well assays that offer a rapid, cost-effective way to measure IgG. Valita Titer is among the industry’s fastest IgG tests and is compatible with all plate readers with a Fluorescence Polarization module.
Measure IgG directly in cell suspension
- Simple: Add, mix & read
- Rapid: Results in less than 15 minutes
- Automation friendly: 3 steps in standard plates
- Value for money: Competition-beating prices
Straight from culture to plates and results
- No sample preparation
- No additional reagents
- No wash
Here’s why automating IgG quantification matters:
1.
Speed and Efficiency:
- The Valita®Titer assay delivers rapid results. Quantify 96 IgG samples in just 15 minutes —a remarkable improvement over time-consuming alternatives.
- When automated on Beckman’s i-Series liquid handlers, you can process 456 samples in less than an hour. This unprecedented speed accelerates research and production timelines.
2.
Economic Benefits:
- Traditional techniques like HPLC and surface interferometry require specialized instrumentation and highly skilled analysts. These come with a high capital expenditure (CAPEX) investment.
- In contrast, the Valita®Titer assay is cost-effective. It eliminates the need for complex equipment and skilled operators, making it an economical choice.
3.
Automation Relieves Labour Burden:
- Manual ELISA and other quantification methods involve repetitive steps, leading to human error and variability.
- By automating the Valita®Titer assay, you reduce labour-intensive tasks, enhance reproducibility, and free up scientists’ time for more valuable work.
4.
Quantification in the Presence of Cells:
- Unlike some techniques, the Valita®Titer assay works even when cells are present in the sample.
- Its two-step workflow and short incubation time allow efficient preparation and quantification of IgG samples.
Say goodbye to tedious processes and embrace the future of bioanalysis
1
The Valita Titer IgG quantification assayplate -
2
The Biomek i5 responsible for standard curve creation and plating of standards and samples
-
3
Molecular Devices SpectraMax iD5 reader, which performed FP measurement on the Valita Titer assay plate.
- Increased throughput for IgG quantification using Valita Titer 384-well plates
- Rapid Rabbit IgG Quantification using the Valita Titer Assay
- Improved data quality of plate-based IgG quantification using Spark®’s enhanced optics
- High-throughput IgG quantitation platform for clone screening during drug discovery and development
- Rapid Measurement of IgG Using Fluorescence Polarization
- A High-Throughput, Automated Screening Platform for IgG Quantification During Drug Discovery and Development
- A fully automated plate-based optimization of fed-batch culture conditions for monoclonal antibody-producing CHO cell line
Automating the Valita Titer Assay
The Valita Titer assay easily integrates into automated workflows to provide a fully automated IgG quantification platform.
In summary, the Valita®Titer assay, combined with Beckman’s i-Series liquid handlers, provides a high-throughput, fully automated solution for accurate IgG quantification
Discuss your specific requirements with our experts and let us enhance IgG quantification Workflows.
Ask our experts